Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Other financing activities (2020 - 2025)

Historic Other financing activities for Sanara MedTech (SMTI) over the last 8 years, with Q3 2025 value amounting to $1.2 million.

  • Sanara MedTech's Other financing activities rose 22018.8% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year increase of 7766.04%. This contributed to the annual value of $4.4 million for FY2024, which is 2885.29% up from last year.
  • Sanara MedTech's Other financing activities amounted to $1.2 million in Q3 2025, which was up 22018.8% from $1.4 million recorded in Q2 2025.
  • Sanara MedTech's Other financing activities' 5-year high stood at $4.5 million during Q4 2024, with a 5-year trough of -$1.0 million in Q3 2024.
  • In the last 5 years, Sanara MedTech's Other financing activities had a median value of $857526.0 in 2023 and averaged $1.2 million.
  • As far as peak fluctuations go, Sanara MedTech's Other financing activities skyrocketed by 43450.16% in 2022, and later tumbled by 21958.02% in 2024.
  • Over the past 5 years, Sanara MedTech's Other financing activities (Quarter) stood at $728482.0 in 2021, then surged by 434.5% to $3.9 million in 2022, then decreased by 7.72% to $3.6 million in 2023, then rose by 25.91% to $4.5 million in 2024, then plummeted by 72.76% to $1.2 million in 2025.
  • Its last three reported values are $1.2 million in Q3 2025, $1.4 million for Q2 2025, and $1.3 million during Q1 2025.